I do not have specific information, but I have heard that Pfizer and GSK filed MODRs.

Join Dr. Joachim Ermer from Ermer Quality Consulting to learn more about ICH Q2 Revision 2 and the Objectives of Method Development and Validation (Analytical Target Profile).

Watch the On-Demand presentation now: https://bio-qc.com/ich-q2-revision-2-and-method-development-and-validation-objectives-analytical-target-profile/

Plus, don’t miss his expert insights during the panel discussion on Addressing Challenges in Analytical Validation: Understanding ICH Q2(R2) and Integration with ICH Q14.